Skip to content

Het gebruik van verschillende soorten langdurige medicatie bij ouderen in de huisartsenpraktijk.

Medication Review in patients with Polypharmacy in primary care: Effects of the Clinical Rules Engine and the Outcome Prioritisation Tool on Patient and Clinical Outcomes: CRE-OPT study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27441
Enrollment
360
Registered
2018-05-14
Start date
2019-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polypharmacy, medication review, decision support software, patient preferences, outcome prioritization, treatment satisfaction

Interventions

Integral medication review, including a home visit by the nurse practitioner, and consultation of GP and pharmacist, but augmented with sophisticated medication review software (‘Clinical Rules Engine

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged >=65 years with at least 5 chronic medication prescriptions in at least two different organ systems.

Exclusion criteria

Exclusion criteria: Patients who cannot act for themselves, patients with insufficient knowledge of Dutch language, patients with a life-expectancy of less than one year (according to the GP) and patients who already had a medication review in the last 12 months.

Design outcomes

Primary

MeasureTime frame
Main outcome is treatment satisfaction with prescribed medication

Secondary

MeasureTime frame
Secondary outcomes are type and number of medication alerts, changes in medication prescription, medication adherence, drug burden index, and quality of life. Relevant outcomes will be measured at baseline (before the intervention), after completion of the intervention, and after 12 months follow-up.

Contacts

Public ContactM. Akker, van den

Postbus 616

marjan.vandenAkker@HAG.unimaas.nl+31 (0)43 3882321

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)